Amplified Amplitudes of Circadian Rhythms and Nighttime Hypotension in Patients with Chronic Fatigue Syndrome: Improvement by Inopamil But Not by Melatonin

Abstract

Fatigue is an important symptom of a disturbed circadian rhythm. To date, no studies of circadian rhythms in patients with chronic fatigue syndrome (CFS) have been published. The objectives of the study were to study rhythms of heart rate and systolic and diastolic blood pressure in patients with chronic fatigue syndrome compared with age-matched normotensive controls and to study the effects of melatonin and inopamil on such rhythms.

Ambulatory blood pressure (ABP) measurements (Space Lab, Inc, validated) of 18 patients with CFS were made according to the 1987 U.S. Center for Disease Control Criteria, and measurements of 12 age-matched normotensive controls were used in a cosinor analysis of the two groups. The effects of melatonin and inopamil on ABP were studied subsequently in four patients in an 8-week open-label evaluation.

One patient was hypertensive (diastolic blood pressure > 90 mm Hg at least once every 4 hours), and was, therefore, excluded. The data of the remaining 17 patients (15 women, 2 men) revealed a significant 12-hour rhythm in heart rate and 24-hour rhythm in systolic and diastolic blood pressure with 95% confidence intervals not significantly different from sinusoidal patterns. Although these rhythms were synchronous with the control group rhythms, their amplitudes were not and showed, respectively, 2.8, 2.8, and 9.0 times the size of the control group rhythms (p < 0.001, p < 0.001, and p < 0.0001, respectively). Systolic blood pressures in the patients with CFS were consistently below 100 mm Hg during the nighttime. In a subsequent pilot study of four patients from the study population treated with melatonin 4 mg daily and inopamil 200 mg daily for 4 weeks, inopamil reduced nighttime hypotension (p<0.05), whereas melatonin increased nighttime hypotension (p < 0.02).

Patients with CFS have increased amplitudes of circadian rhythms and systolic blood pressures consistently below 100 mm Hg during the nighttime. Positive inotropic compounds may be beneficial in such patients, but melatonin may not be.

Get full access to this article

View all access options for this article.

References

Rietveld WJ , Kerkhof GA : De biologische klok, praktische toepassingen in kliniek In: Boerhaave Commissie voor Postacademisch Onderwijs in de Geneeskunde, ed. by Rietveld WJ, Kerkhof GA. Leiden: Rijksuniversiteit editie, 1993, pp 1-9.

Lemmer B. , Scheidel B. , Blume H., et al : Clinical chronopharmacology and chronopharmacodynamics of cardiovascular drugs in healthy subjects Eur J Clin Pharmacol 40:71-75, 1991.

Bou-Holaigah I. , Rowe PC , Kan J., et al : The relationship between neurally mediated hypotension and the chronic fatigue syndrome JAMA 274:961-967, 1995.

Freeman R. , Komaroff AL : Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 102:357-362, 1997.

Arendt J. , Aldhous M. , Marks V. : Alleviation of jet-lag by melatonin: preliminary results of controlled double-blind trial Br Med J 292:1170-1174, 1986 .

Arendt J. , Aldhous M. , English J., et al : Some effects of jet lag and their alleviation by melatonin Ergonomics 30:1379-1393, 1987.

Harvard Graphics-3: Statistical Software Boston: Harvard Inc, 1995.

Buchwald D. , Pearlman T. , Umali J., et al : Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses and healthy individuals Am J Med 101:364-370, 1996.

Demitrack MA , Abbey SE : An integrative approach to evaluation and treatment In: Chronic Fatigue Syndrome, ed. by Demitrack MA, Abbey SE. New York: Guilford Press, 1996, pp 222-241.

10.

Hickie I. , Lloyd A. , Wakefield D., et al : The psychiatric status of patients with chronic fatigue syndrome Br J Psychiatry 156:534-540, 1990.

11.

Kruesi Mjp , Dale J. , Straus SE : Psychiatric diagnoses in patients who have chronic fatigue syndrome J Clin Psychiatry 50:53-56, 1989.

12.

Katon WJ , Buchwald DS , Simon GE, et al : Psychiatric illness in patients with chronic fatigue syndrome J Gen Intern Med 6:277-285, 1991.

13.

Schwartz RB , Komaroff AL , Garada BM : SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, and major unipolar depression . Am J Roentgenol 162:943-951, 1994.

14.

Vercoulen JH , Swanink CM , Zitman FG : Randomised double-blind placebo-controlled study of fluoxetine in chronic fatigue syndrome Lancet 347:858-861, 1996.

15.

Cleare AJ , Bearn J. , Allain T. : Contrasting neuroendocrine responses in depression and chronic fatigue syndrome J Affect Disord 35:283-289, 1995.

16.

Fulcher KY , White PD : Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome Br Med J 314:1647-1652, 1997.

17.

Cleophas TJ : Depression and myocardial infarction: Implications for medical prognosis and options for treatment. Drugs Aging 11:1170-1177, 1997.

18.

Anonymous: Chronic fatigue syndrome. Health agencies update JAMA 277:873, 1997.

19.

Demitrack MA , Dale JK , Straus SE : Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome J Clin Endocrinol Metab 73:1224-1234, 1991.

20.

Lewy AJ , Wehr TA , Goodwin FK : Light suppresses melatonin secretion in humans. Science 210:1267-1269, 1980.

21.

Williams G. , Pirmohamed J. , Minors D., et al : Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome Clin Physiol 16:327-337, 1996.

22.

Samel TL , Wegman HM , Vejvoda M., et al : Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9 hour shift J Biol Rhythms 6:235-248, 1991.